Delivery Order SPE2DB22D3004-SPE2DB24FQG55
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Erythromycin 0.5% eye ointment. The delivery order, valued at $5,755.04, has a firm fixed price and an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,243.04 firm fixed-price delivery order contract is for the supply of Erythromycin 0.5% eye ointment to support military healthcare programs. The contract has an ultimate completion date of September 29, 2023 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,243.61, is for the delivery of Erythromycin 0.5% Eye Ointment 3.5GM. It is a firm fixed-price delivery order contract with a completion date of December 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, with a ceiling value of $10,738.67, is for the delivery of Erythromycin 0.5% eye ointment. It is a firm fixed-price delivery order contract with an ultimate completion date of April 4, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,479.57 contract is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams, with a performance period through April 30, 2024. The contract is a firm fixed-price agreement with no set-aside requirements. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,189.60 firm fixed-price contract is for the delivery of Erythromycin 0.5% Eye Ointment, a pharmaceutical product, with a period of performance through November 18, 2024. The contract was not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Erythromycin 0.5% Eye Ointment, 3.5 grams, with a total ceiling value of $1,741.51. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of May 6, 2024. There was no set-aside designation for this award. AmerisourceBergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.5% erythromycin eye ointment, a medical supply item, with a ceiling value of $1,169.08 and a performance period ending on January 29, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds a significant...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,604.48 firm fixed-price contract is for the delivery of Erythromycin 0.5% eye ointment, a topical antibiotic medication, with a completion date of January 10, 2025. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566338491 - Erythromycin 0.5% Eye Ointment, 3.5 grams, with a ceiling value of $1,526.92. The contract is a firm fixed-price, delivery order contract with a period of performance through November 6, 2024. Amerisourcebergen is a for-profit organization...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FQG55Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Erythromycin 0.5% Eye Ointment 3.5GM, a pharmaceutical product, with a ceiling value of $1,561.58 and a completion date of May 8, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 5/7/24 |